# Cadila Pharmaceuticals Limited, Ankleshwar, India – FDA Inspections

Source: https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025

> Inspection records and compliance data for Cadila Pharmaceuticals Limited in Ankleshwar. 6 FDA inspections on record (2 OAI), 1 Form 483, last inspected May 10, 2024.

---

## Details

- Name: Cadila Pharmaceuticals Limited
- FEI Number: 3002806711
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK
- Address Line 1: 294, G.I.D.C. Industrial Estate
- City: Ankleshwar
- Country Name: India
- Address: 294, G.I.D.C. Industrial Estate, Ankleshwar, India
- Country: India

## Related Documents

- [483 - Cadila Pharmaceuticals Limited - 2024-05-10](https://www.keypedia.com/records/483/cadila-pharmaceuticals-limited/7f625ff3-ac7f-4626-bb20-df3fe1487e26) — source: FDA, date: May 10, 2024
- FDA Inspection 1239090 - Cadila Pharmaceuticals Limited - 2024-05-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2024
- [FDA Inspection 1102381 - Cadila Pharmaceuticals Limited - 2019-08-09](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/c46cb87f-671f-483c-a547-23b179476c00) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 9, 2019
- FDA Inspection 1044877 - Cadila Pharmaceuticals Limited - 2018-02-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2018
- [FDA Inspection 982066 - Cadila Pharmaceuticals Limited - 2016-07-25](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/1dee8c78-60d2-4392-b9a9-fa0a0d0b3ec7) — classification: Official Action Indicated (OAI), source: FDA, date: July 25, 2016
- [FDA Inspection 873262 - Cadila Pharmaceuticals Limited - 2014-03-28](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/c6483e74-582a-49cb-9785-fe9c2d0c37ff) — classification: Official Action Indicated (OAI), source: FDA, date: March 28, 2014
- [FDA Inspection 664596 - Cadila Pharmaceuticals Limited - 2009-12-11](https://www.keypedia.com/records/fda_inspections/cadila-pharmaceuticals-limited/5941e593-4a28-44a5-8fad-01226579a578) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2009

## Related Companies

- [Harman Finochem Limited](https://www.keypedia.com/companies/harman-finochem-limited/7622941a-bad2-45c3-bd91-07d2bb63f905)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)

## Related Officers

- [Alan A. Rivera](https://www.keypedia.com/people/alan-a-rivera/4bec02c3-c62e-4b3a-a6ab-02c3386549bf)
- [Angelica M. Hernandez](https://www.keypedia.com/people/angelica-m-hernandez/d66d920c-01b6-4770-a1b5-cac9a1790a0e)
